RNA, 7SL, cytoplasmic 213, pseudogene (RN7SL213P)

RN7SL213P is one of hundreds of dispersed human 7SL pseudogenes, which occur when RNA from the canonical 7SL gene is reverse-transcribed and inserted into the genome[5]. These pseudogenes are nearly always truncated and do not produce functional RNA, nor do they encode protein[5]. The canonical 7SL RNA functions as a scaffold for the SRP, which directs co-translational transport of proteins into the endoplasmic reticulum[1][3]. However, pseudogenes such as RN7SL213P do not participate in this process and are not known to have biological or therapeutic function[5]. A "pseudogene" designation indicates this locus is generally neither transcribed nor translated into functional products, and it is not a recognized receptor, enzyme, transporter, or other molecular therapeutic target[2][5]. RN7SL213P is not used as a biomarker, not associated with clear disease roles, not targeted by any drugs (and no mechanisms of action are known), and has no specific associated safety concerns. The entry is not a therapeutic target (such as a receptor, transporter, or enzyme); it is a pseudogene. The formal gene symbol (HGNC-approved abbreviation) is RN7SL213P, matching your query. Most literature relevant to function, interactors, or disease discusses functional 7SL RNA genes (e.g., RN7SL1), not their pseudogenes[1][3][5]. If you are seeking information about the functional SRP RNA gene (RN7SL1), refer to "RNA, 7SL, cytoplasmic 1" instead[1][6]. There is no indication of common biological function, disease role, drug interaction, or biomarker utility for RN7SL213P. No spelling errors are apparent, but the target is not suitable for therapeutic targeting or molecular classification as a functional receptor or enzyme.

Other names

RN7SL213P7SL pseudogeneRNA, 7SL, cytoplasmic pseudogene